1 August 17, 2018 Subject: Capital Increase for Offering for Sale to Specific Investors (Private Placement), Connected Transaction, Amendments to Articles of Association/Objectives of the Company and
General Shareholders’ Meeting report Agenda 2 Acknowledge the performance of UREKA for the year 2019 and Annual Report 2019 Opinion of the Board of Directors See as appropriate for the company to present
information: (1) the method of procuring loan, for instance, applying for a loan from a financial institution or issuing a debenture. In any case, the Company shall present highlights of the loan agreement or
present, the mentioned investments are under negotiation with relevant parties and have no clear conclusion that can be disclosed at this moment. Initially, the Company expected that the first investments
financing. At present, the mentioned investments are under negotiation with relevant parties and have no clear conclusion that can be disclosed at this moment. Initially, the Company expected that the first
oversubscription allotment. At present, Mr.Vorasit hold shares of the Company in an amount of 45,256,855 shares; therefore, the shares received from RO allotment is approximately 18,102,742 shares and Mr.Vorasit
shares, which includes shares received from RO allotment and from oversubscription allotment. At present, Mr.Vorasit hold shares of the Company in an amount of 45,256,855 shares; therefore, the shares
instead of producing only one or two types of products as in present. Moreover, the Company has the policy of transparency based on good governance. Therefore, the Audit Committee has the opinion that the
restructuring. At present, the NYK Group has already completed the business restructuring process. The Company would like to exercise the right to make investment in LRT through the purchase of 29 percent of NYKT